Centralised authorisation procedure 2015

The Danish share of assignments in the European pharmaceutical collaboration.

The Danish Medicines Agency should have the greatest possible influence on decisions regarding new medicinal products and thereby the greatest possible influence on the future development of the European market for medicinal products.

Status for 2015 up to and including 4th quarter

Denmark was assigned 7,5 human rapporteur/co-rapporteur cases and 9 veterinary rapporteur/co-rapporteur cases, which are respectively 3 % and 14 % of all assigned central procedure cases in 2015.

Figure 1. Amount of assigned rapporteur/corapporteur cases in the EU in 2015 up to and including 4th quarter

Figure 2. Share of human rapporteur/corapporteur cases in the EU in 2015 up to and including 4th quarter

View table 1 – Assigned human rapporteur/co-rapporteur cases

Figure 3. Share of veterinary rapporteur/corapporteur cases in the EU in 2015 up to and including 4th quarter

View table 2 - Assigned veterinary rapporteur/co-rapporteur cases